{
  "ticker": "PAB",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972006",
  "id": "02972006",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250723",
  "time": "1853",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m2d8myn2883x.pdf",
  "summary": "**Capital Raising Announcement**  \n\n- **Structure**: Non-renounceable entitlement offer (3:4 ratio) at A$0.001 per share, with 1 free-attaching share for every 4 applied for.  \n- **Total raised**: ~A$1.774 million (before costs).  \n- **Use of proceeds**: Technical/commercial work for deoxymabs (partnering, manufacturing review), IP maintenance, business development, working capital.  \n- **Underwritten**: Fully by Templar Corporate Pty Ltd; directors sub-underwrite A$225k.  \n- **Timetable**:  \n  - Ex-date: 31 July 2025  \n  - Record date: 1 August 2025  \n  - Closing date: 21 August 2025  \n  - Expected issue/trading: 28\u201329 August 2025.  \n- **Effective cost**: A$0.0008 per share (due to free-attaching shares).  \n\n*Omitted: Routine terms, director names, non-material risk disclosures.*",
  "usage": {
    "prompt_tokens": 2148,
    "completion_tokens": 218,
    "total_tokens": 2366,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T09:15:04.950337"
}